Abstract
A preterm infant with early onset Morganella morganii sepsis was treated with cefotaxime and gentamicin after confirmation of antimicrobial susceptibility. The infant developed persistent ventriculitis caused by the emergence of a cefotaxime-resistant Morganella variant with derepression of its AmpC β-lactamase. When choosing antibiotic therapy, the risk of development of resistance to cephalosporins should be considered in infections caused by M. morganii and other Gram-negative organisms with inducible AmpC β-lactamases.
Original language | English |
---|---|
Pages (from-to) | 376-377 |
Number of pages | 2 |
Journal | Pediatric Infectious Disease Journal |
Volume | 25 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2006 |
Bibliographical note
Copyright:Copyright 2008 Elsevier B.V., All rights reserved.
Keywords
- AmpC β-lactamases
- Morganella morganii
- Newborn
- Sepsis
- β-lactamases